BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24413619)

  • 21. Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers.
    Schöll M; Almkvist O; Bogdanovic N; Wall A; Långström B; Viitanen M; Nordberg A
    J Alzheimers Dis; 2011; 24(3):495-506. PubMed ID: 21297272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a Pathogenic PSEN1 Ala285Val Mutation Associated with Early-Onset Alzheimer's Disease.
    Vo VG; Pyun JM; Bagyinszky E; An SSA; Kim SY
    Curr Alzheimer Res; 2020; 17(5):438-445. PubMed ID: 32589559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Presenilin 1 Mutation in Early-Onset Alzheimer's Disease With Prominent Frontal Features.
    Nygaard HB; Lippa CF; Mehdi D; Baehring JM
    Am J Alzheimers Dis Other Demen; 2014 Aug; 29(5):433-5. PubMed ID: 24463146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel presenilin 1 mutation (p.F386I) in a Chinese family with early-onset Alzheimer's disease.
    Shea YF; Chan AO; Chu LW; Lee SC; Law CY; See CH; Yiu KL; Chiu PK
    Neurobiol Aging; 2017 Feb; 50():168.e9-168.e11. PubMed ID: 27816212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial Alzheimer's disease mutations in presenilin 1 do not alter levels of the secreted amyloid-beta protein precursor generated by beta-secretase cleavage.
    Zhang C; Browne A; Kim DY; Tanzi RE
    Curr Alzheimer Res; 2010 Feb; 7(1):21-6. PubMed ID: 20205669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation.
    Bruni AC; Bernardi L; Colao R; Rubino E; Smirne N; Frangipane F; Terni B; Curcio SA; Mirabelli M; Clodomiro A; Di Lorenzo R; Maletta R; Anfossi M; Gallo M; Geracitano S; Tomaino C; Muraca MG; Leotta A; Lio SG; Pinessi L; Rainero I; Sorbi S; Nee L; Milan G; Pappatà S; Postiglione A; Abbamondi N; Forloni G; St George Hyslop P; Rogaeva E; Bugiani O; Giaccone G; Foncin JF; Spillantini MG; Puccio G
    Neurology; 2010 Mar; 74(10):798-806. PubMed ID: 20164095
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Quiroz YT; Aguillon D; Aguirre-Acevedo DC; Vasquez D; Zuluaga Y; Baena AY; Madrigal L; Hincapié L; Sanchez JS; Langella S; Posada-Duque R; Littau JL; Villalba-Moreno ND; Vila-Castelar C; Ramirez Gomez L; Garcia G; Kaplan E; Rassi Vargas S; Ossa JA; Valderrama-Carmona P; Perez-Corredor P; Krasemann S; Glatzel M; Kosik KS; Johnson K; Sperling RA; Reiman EM; Sepulveda-Falla D; Lopera F; Arboleda-Velasquez JF
    N Engl J Med; 2024 Jun; 390(23):2156-2164. PubMed ID: 38899694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trans-dominant negative effects of pathogenic PSEN1 mutations on γ-secretase activity and Aβ production.
    Heilig EA; Gutti U; Tai T; Shen J; Kelleher RJ
    J Neurosci; 2013 Jul; 33(28):11606-17. PubMed ID: 23843529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease.
    Gao Y; Ren RJ; Zhong ZL; Dammer E; Zhao QH; Shan S; Zhou Z; Li X; Zhang YQ; Cui HL; Hu YB; Chen SD; Chen JJ; Guo QH; Wang G
    Neurobiol Aging; 2019 May; 77():154-157. PubMed ID: 30822634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel pathogenic PSEN1 mutation in a family with Alzheimer's disease: phenotypical and neuropathological features.
    Gallo M; Marcello N; Curcio SA; Colao R; Geracitano S; Bernardi L; Anfossi M; Puccio G; Frangipane F; Clodomiro A; Mirabelli M; Vasso F; Smirne N; Muraca G; Di Lorenzo R; Maletta R; Ghidoni E; Bugiani O; Tagliavini F; Giaccone G; Bruni AC
    J Alzheimers Dis; 2011; 25(3):425-31. PubMed ID: 21422519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype.
    De Jonghe C; Cras P; Vanderstichele H; Cruts M; Vanderhoeven I; Smouts I; Vanmechelen E; Martin JJ; Hendriks L; Van Broeckhoven C
    Neurobiol Dis; 1999 Aug; 6(4):280-7. PubMed ID: 10448055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel PSEN1 gene mutation (L235R) associated with familial early-onset Alzheimer's disease.
    Antonell A; Balasa M; Oliva R; Lladó A; Bosch B; Fabregat N; Fortea J; Molinuevo JL; Sánchez-Valle R
    Neurosci Lett; 2011 May; 496(1):40-2. PubMed ID: 21501661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel presenilin 1 mutation (F388L) identified in a Chinese family with early-onset Alzheimer's disease.
    Zhan Y; Zheng H; Wang C; Rong Z; Xiao N; Ma Q; Zhang YW
    Neurobiol Aging; 2017 Feb; 50():168.e1-168.e4. PubMed ID: 27836335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PSEN1 variants in Korean patients with clinically suspicious early-onset familial Alzheimer's disease.
    Kim YE; Cho H; Kim HJ; Na DL; Seo SW; Ki CS
    Sci Rep; 2020 Feb; 10(1):3480. PubMed ID: 32103039
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Bagyinszky E; Lee HM; Van Giau V; Koh SB; Jeong JH; An SSA; Kim S
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer's disease.
    Van Giau V; Pyun JM; Suh J; Bagyinszky E; An SSA; Kim SY
    BMC Neurol; 2019 Aug; 19(1):188. PubMed ID: 31391004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Aβ42/Aβ40 ratio.
    Qiu Q; Shen L; Jia L; Wang Q; Li F; Li Y; Jia J
    J Alzheimers Dis; 2019; 69(1):199-212. PubMed ID: 30958370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.
    Ryan NS; Nicholas JM; Weston PSJ; Liang Y; Lashley T; Guerreiro R; Adamson G; Kenny J; Beck J; Chavez-Gutierrez L; de Strooper B; Revesz T; Holton J; Mead S; Rossor MN; Fox NC
    Lancet Neurol; 2016 Dec; 15(13):1326-1335. PubMed ID: 27777022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel presenilin 1 mutation (V261L) associated with presenile Alzheimer's disease and spastic paraparesis.
    Jiménez Caballero PE; Lladó A; de Diego Boguna C; Martin Correa E; Serviá Candela M; Marsal Alonso C
    Eur J Neurol; 2008 Sep; 15(9):991-4. PubMed ID: 18637955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autosomal dominant Alzheimer's disease with early frontal lobe involvement associated with the Met239Ile mutation of Presenilin 2 gene.
    Testi S; Fabrizi GM; Pompanin S; Cagnin A
    J Alzheimers Dis; 2012; 31(1):7-11. PubMed ID: 22531416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.